Breyanzi (lisocabtagene maraleucel) - BMS
Kymriah (tisagenlecleucel-T) - Novartis
CTX112 - CRISPR Therap
Isocel (ALEXIS-ISO-1) - Kiromic
FT596 - Fate Therap
Rituxan (rituximab) - Roche
TAK-007 - Takeda, UT MD Anderson Cancer Center
GDA-201 - Ayrmid
HSP-CAR30 - Hospital of the Holy Cross and Saint Paul
Yescarta (axicabtagene ciloleucel) - Gilead
Actemra IV (tocilizumab) - Roche, JW Pharma
prizloncabtagene autoleucel (JNJ-4496) - J&J
AUTO4 - Autolus
zamtocabtagene autoleucel (MB-CART2019.1) - Miltenyi Biotec
cemacabtagene ansegedleucel (ALLO-501A) - Allogene Therap
https://clml-25-01.elsevierdigitaledition.com/
 
Hanan Alharthy, MD 1; Sairah Ahmed, MD 1, 2*
 
Aug 26, 2025
 
Next